Evidence map›Paper›PMID 27767006›Full record

ArticleEmerging infectious diseases2016

Global Escherichia coli Sequence Type 131 Clade with bla

Yasufumi Matsumura, Johann D D Pitout, Ryota Gomi, Tomonari Matsuda, Taro Noguchi, Masaki Yamamoto, Gisele Peirano, Rebekah DeVinney, Patricia A Bradford, Mary R Motyl and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Prevalence of antimicrobial-resistantOne health (Amsterdam, Netherlands) · 2026
    Article
  4. Article
  5. Article
  6. A community-based One Health approach to the pandemic dynamics ofAntimicrobial agents and chemotherapy · 2026
    Article
  7. Genomic Characterization of Selected Multidrug-ResistantAnimals : an open access journal from MDPI · 2026
    Article
  8. Phenotypic and Genetic Characteristics ofInternational journal of molecular sciences · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mobile genetic elements of global Escherichia coli ST131 clades with carbapenemases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Yasufumi Matsumura
Johann D D Pitout
Ryota Gomi
Tomonari Matsuda
Taro Noguchi
Masaki Yamamoto
Gisele Peirano
Rebekah DeVinney
Patricia A Bradford
Mary R Motyl
Michio Tanaka
Miki Nagao
Shunji Takakura
Satoshi Ichiyama
Kyoto University · JPMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Calgary · CAAstraZeneca (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Escherichia coli sequence type (ST) 131 C2/H30Rx clade with the bla

Indexed as

Genotypebeta-LactamasesEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsGlobal HealthHumansbeta-LactamasesEscherichia coli Proteinsantimicrobial resistancebacteriabla geneclonesCTX-M-27E. coliEscherichia colihigh-throughput DNA sequencingMLSTmolecular epidemiologymultilocus sequence typingβ-lactamases

Identifiers

PMID27767006
PMCPMC5088012
OpenAlexW2527109340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.